TEM
Tempus AI, Inc. · Healthcare · Medical - Healthcare Information Services
Momentum inputs (comparable managers):
holder breadth +5.6% ·
share flow +12.8% ·
net new positions 0.0%
· formula
Broad accumulation: rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 23.85K | $1.65M | n/a | n/a |
| Q2 2026 | 105 | -4 | 78.05M | $4.52B | +6 | −11 |
| Q1 2026 | 113 | -8 | 69.19M | $3.11B | +9 | −18 |
| Q4 2025 | 122 | 0 | 71.01M | $4.19B | +2 | −1 |
| Q3 2025 | 19 | +1 | 54.18M | $4.37B | +2 | −2 |
| Q2 2025 | 16 | +5 | 35.66M | $2.27B | +6 | −1 |
| Q1 2025 | 8 | +2 | 9.48M | $457.55M | +3 | −1 |
| Q4 2024 | 6 | +1 | 7.54M | $254.48M | +2 | −1 |
| Q3 2024 | 5 | -2 | 10.12M | $572.43M | n/a | −2 |
| Q2 2024 | 7 | n/a | 7.72M | $270.21M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | JPMorgan Chase ✦ | 9.86M | n/a | $795.70M | 0.0% | n/c | 1 | SEC ↗ ×22 |
| 2 | Baillie Gifford ✦ | 9.69M | -19.9% | $782.28M | 0.6% | ▼ Trim | 2 | SEC ↗ ×4 |
| 3 | The Vanguard Group ✦ (passive) | 9.44M | +22.1% | $762.03M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 4 | ARK Investment Management ✦ | 7.18M | -3.3% | $579.16M | 3.4% | ▼ Trim | 6 | SEC ↗ |
| 5 | BlackRock ✦ (passive) | 6.74M | +62.8% | $543.76M | 0.0% | ▲ Add | 2 | SEC ↗ ×16 |
| 6 | Morgan Stanley ✦ | 2.42M | n/a | $195.01M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 7 | D. E. Shaw & Co. ✦ | 2.03M | +380.8% | $163.64M | 0.1% | ▲ Add | 3 | SEC ↗ ×2 |
| 8 | Geode Capital Management ✦ (passive) | 1.73M | +166.2% | $139.56M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 9 | State Street Global Advisors ✦ (passive) | 1.47M | +71.3% | $118.86M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Two Sigma Investments ✦ | 1.23M | +3.5% | $99.62M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 904.87K | +6.4% | $73.03M | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
| 12 | T. Rowe Price ✦ | 615.71K | +1924.4% | $49.70M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 13 | Renaissance Technologies ✦ | 444.30K | New | $35.86M | 0.0% | New | 1 | SEC ↗ |
| 14 | Goldman Sachs Group ✦ | 225.75K | n/a | $18.22M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 15 | Millennium Management ✦ | 113.39K | +413.9% | $9.15M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 16 | Marshall Wace ✦ | 61.09K | +476.3% | $4.93M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 17 | Citadel Advisors ✦ | 17.55K | -80.2% | $1.42M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 18 | Gotham Asset Management ✦ | 7.23K | New | $583,775 | 0.0% | New | 1 | SEC ↗ |
| 19 | Fidelity (FMR) ✦ | 2.93K | +1344.3% | $236,648 | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Renaissance Technologies | $35.86M | 0.0% |
| Gotham Asset Management | $583,775 | 0.0% |
Exited
| Norges Bank | $9.02M | was 0.0% |
| Bridgewater Associates | $242,405 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 13.60K shares, $614 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 10.28K sh · $873,885
Officer, Director, 10% owner · 6.43K sh · $492,422
Officer, Director, 10% owner · 24 sh · $1,893
Officer, Director, 10% owner · 2.09K sh · $163,579
Officer, Director, 10% owner · 33.77K sh · $2.61M
Officer, Director, 10% owner · 17.36K sh · $1.33M
Officer, Director, 10% owner · 29.37K sh · $2.27M
Officer, Director, 10% owner · 965 sh · $73,890
Officer, Director, 10% owner · 37.95K sh · $2.97M
Officer, Director, 10% owner · 4.42K sh · $341,622
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology